ORTEXORTEX News
Tracking GILD? Get live short interest, options flow, and signals on ORTEX.Sign up free →
GI
ConfluenceGILD

GILD Bears Exit as Options Market Turns Bullish

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 25 Sept 2026, 11:32

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of Gilead Sciences, Inc. (GILD) share price and short interest (% of free float), three months to September 24, 2026
ORTEX data as of 25 Sept 2026, 11:32

Short sellers are fleeing GILD. The options market is leaning bullish. The two signals are pointing the same way.

Short Covering Accelerates

Short interest fell 20.3% in a single day on September 24. It now stands at just 1.47% of free float — down 25.2% over the past month.

This is a four-week covering trend that compressed dramatically in the final session. At these levels, short interest carries little weight as a bearish signal. The borrow market reflects the same picture: availability is effectively unconstrained, with ample shares to borrow and cost-to-borrow at just 0.55%.

The covering isn't driven by a squeeze. There's no borrow stress. This looks like voluntary position reduction.

Options Traders Shift Toward Calls

The put/call ratio hit 0.51 on September 24. The 20-day mean is 0.54. The z-score is -1.29 — statistically tilted toward calls relative to recent norms.

The 52-week PCR range runs from 0.40 to 0.92. The current reading sits in the lower third. Options positioning has drifted steadily more call-heavy since mid-September, as the PCR declined from 0.58 to its current level.

That's options traders reducing downside hedges as shorts cover. Both groups moving in the same direction at the same time is the convergence worth watching.

Earnings Revisions Stay Strong

This consistency supports what the previous ORTEX note flagged: EPS momentum ranks in the 93rd and 95th percentiles over 30- and 90-day windows respectively. Estimate revisions have been running hot even as the stock pulled back slightly — down 1.1% Thursday, flat on the week.

The analyst picture remains split. HSBC raised its target to $175 (from $155) on September 10. The consensus sits at $158.65 against a current price of $149.69. T. Rowe Price added 3.79 million shares in the most recent reporting period — the largest institutional build in the top-15 holder list.

The ORTEX short score is stable at 32.9, near its recent range low. Nothing in the lending market suggests renewed short pressure is building.

Data Summary

  • SI % of free float: 1.47% (Sept 24), down from 1.96% a week ago
  • 1-day SI change: –20.3%
  • 1-month SI change: –25.2%
  • Cost to borrow: 0.55% (up 43% on the week, but from a very low base)
  • Availability: Unconstrained
  • PCR: 0.51 vs 20-day mean of 0.54; z-score –1.29
  • EPS momentum: 93rd pct (30d), 95th pct (90d)
  • Next earnings: November 6, 2026

Against its own history

This week's change in short interest is 3.8 standard deviations below the company's typical weekly move over the past year.

Against its peers

Shares moved -0.8% over the past week against a median of -1.5% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open GILD on ORTEX →

How this article was generated

Generated
25 Sept 2026, 11:37
Data as of
25 Sept 2026, 11:32
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.